| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5207491
Max Phase: Preclinical
Molecular Formula: C19H21N5O2
Molecular Weight: 351.41
Associated Items:
Representations
Canonical SMILES: COc1ccccc1N1CCN(C(=O)Nc2ccc3[nH]ncc3c2)CC1
Standard InChI: InChI=1S/C19H21N5O2/c1-26-18-5-3-2-4-17(18)23-8-10-24(11-9-23)19(25)21-15-6-7-16-14(12-15)13-20-22-16/h2-7,12-13H,8-11H2,1H3,(H,20,22)(H,21,25)
Standard InChI Key: NARUQZSDOFFOCH-UHFFFAOYSA-N
Associated Targets(Human)
Vanilloid receptor 8273 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 351.41 | Molecular Weight (Monoisotopic): 351.1695 | AlogP: 2.93 | #Rotatable Bonds: 3 |
| Polar Surface Area: 73.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.11 | CX Basic pKa: 2.33 | CX LogP: 2.23 | CX LogD: 2.23 |
| Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.76 | Np Likeness Score: -2.08 |
References
| 1. Liang Q, Qiao Z, Zhou Q, Xue D, Wang K, Shao L.. (2022) Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects In Vivo Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core., 65 (17.0): [PMID:36008373] [10.1021/acs.jmedchem.2c00469] |
Source
Source(1):